In a fight for survival, Juul funds pro-vaping studies, then pays a scholarly journal to showcase them
Electronic cigarettes and pods by Juul are offered for sale at the Smoke Depot in Chicago on September 13, 2018. - Scott Olson/Getty Images North America/TNS

In less than two months, the U.S. Food and Drug Administration is supposed to decide, at long last, whether the company most responsible for the teenage vaping epidemic should be stopped, or at least restrained, from marketing its e-cigarettes. The decision will hinge on whether scientific research shows that Juul’s sleek nicotine-delivery device has public health benefits. Does it enable smokers to break or reduce their addiction to cigarettes? Or does it primarily lead to dual use of e-cigs and traditional cigarettes, while luring nonsmokers — especially young people — into nicotine addictio...